159 filings
Page 2 of 8
4
cw2ldk383gmzdn
1 Dec 23
Lantern Pharma / Leslie W. Kreis ownership change
6:00am
8-K
szjeiqv
24 Nov 23
Entry into a Material Definitive Agreement
4:05pm
8-K
31x5ab mni2c6
8 Nov 23
Lantern Pharma Reports Third Quarter 2023 Financial Results and Operational Highlights
4:05pm
8-K
ljcrg53rfyfeh5lst
20 Oct 23
Other Events
5:25pm
8-K
q43b439puqw1
9 Aug 23
Lantern Pharma Reports Second Quarter 2023 Financial Results and Operational Highlights
4:05pm
8-K
zrd2w8ny
21 Jun 23
Submission of Matters to a Vote of Security Holders
4:05pm
8-K
tsdrh
9 May 23
Lantern Pharma Reports First Quarter 2023 Financial Results and Operational Highlights
4:05pm
ARS
zy2qmrg f7
5 May 23
Annual report to shareholders
9:35am
8-K
4m1 s93tzz4l
20 Mar 23
Lantern Pharma Reports Fourth Quarter and Fiscal Year 2022 Financial Results and Operational Highlights
4:05pm
8-K
j4d03e 2o26
18 Jan 23
Departure of Directors or Certain Officers
4:30pm
SC 13G
xt76y12 9s2
21 Nov 22
Lantern Pharma / ProPhase Labs ownership change
4:15pm
4
aytwa2
9 Nov 22
Lantern Pharma / Leslie W. Kreis ownership change
9:39pm
4
e22jpk
9 Nov 22
Lantern Pharma / Aaron G.L. Fletcher ownership change
9:37pm
8-K
3z3tk mhr33da
7 Nov 22
Lantern Pharma Reports Third Quarter 2022 Financial Results and Operational Highlights
4:05pm